Somogyi L, Forsmark C E
Division of Gastroenterology, Hepatology, and Nutrition, University of Florida College of Medicine, Gainesville 32610-0214, USA.
Semin Gastrointest Dis. 1998 Apr;9(2):73-9.
The ability to place endoscopic stents into the pancreatic duct has led to a dramatic increase in stent therapy for benign pancreatic diseases, particularly chronic pancreatitis and pancreas divisum. The overall effectiveness of this therapy remains unknown. This article critically reviews the available literature with a focus on patient selection, efficacy, and risk. The risk of pancreatic duct stenting is only now beginning to be appreciated, and clinicians must understand not only the potential effectiveness of pancreatic duct stenting but also the magnitude of the potential risk when considering this therapy.
将内镜支架置入胰管的能力已使良性胰腺疾病（尤其是慢性胰腺炎和胰腺分裂症）的支架治疗显著增加。这种治疗的总体有效性尚不清楚。本文批判性地回顾了现有文献，重点关注患者选择、疗效和风险。胰管支架置入的风险直到现在才开始受到重视，临床医生在考虑这种治疗时不仅必须了解胰管支架置入的潜在有效性，还必须了解潜在风险的程度。
